loading page

Monomorphic post-transplant lymphoproliferative disorder with plasmablastic differentiation: a challenge for diagnosis and treatment
  • +3
  • Jinjun Cheng,
  • Sarah Harney,
  • Keri Toner,
  • Paige Kube,
  • Metin Ozdemirli,
  • Birte Wistinghausen
Jinjun Cheng
Children’s National Hospital

Corresponding Author:jcheng2@childrensnational.org

Author Profile
Sarah Harney
Children’s National Hospital
Author Profile
Keri Toner
Children’s National Hospital
Author Profile
Paige Kube
Children’s National Hospital
Author Profile
Metin Ozdemirli
MedStar Georgetown University Hospital
Author Profile
Birte Wistinghausen
Children’s National Hospital
Author Profile


Post-transplant lymphoproliferative disorder (PTLD) is a significant complication of solid organ transplantation due to the lifelong immunosuppression (IS), ranging from non-malignant lymphoproliferations to lymphomas. Plasmablastic lymphoma (PBL), a rare and aggressive lymphoma, usually presenting in immunocompromised individuals has been rarely reported in the post-transplant setting. Here we summarize the clinical and pathological features of two children with PBL and history of solid organ transplant.
Submitted to Pediatric Blood & Cancer
30 Apr 2024Assigned to Editor
30 Apr 2024Submission Checks Completed
07 May 20241st Revision Received
08 May 2024Submission Checks Completed
08 May 2024Assigned to Editor
08 May 2024Review(s) Completed, Editorial Evaluation Pending
10 May 2024Editorial Decision: Accept